About Vaporox
Vaporox is a company based in Denver (United States) founded in 2016. Vaporox has raised $2.25 million across 5 funding rounds from investors including Bioventus, Rockies Venture Club and Innosphere. Vaporox operates in a competitive market with competitors including Natrox, EO2Concepts, Advanced Oxygen Therapy, InotecAMD and Numobag, among others.
- Headquarter Denver, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vaporox, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.25 M (USD)
in 5 rounds
-
Latest Funding Round
$280.13 K (USD), Seed
Jun 12, 2023
-
Investors
Bioventus
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Vaporox
Unlock access to complete
Unlock access to complete
Funding Insights of Vaporox
Vaporox has successfully raised a total of $2.25M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $280.13 thousand completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vaporox
Vaporox has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Bioventus, Rockies Venture Club and Innosphere.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Rockies Venture Club is recognized as Colorado’s leading angel investing network.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Healing therapy products are manufactured for medical applications.
|
Locked | Locked | Locked |
Investor details for Vaporox
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vaporox
Investment portfolio details for Vaporox
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vaporox
Detailed financials for Vaporox
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vaporox Comparisons
Peer comparison for Vaporox
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vaporox
Vaporox operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natrox, EO2Concepts, Advanced Oxygen Therapy, InotecAMD and Numobag, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Oxygen-based wound therapy devices are developed for healing non-healing wounds.
|
|
| Locked | Locked | Locked |
Continuous oxygen diffusion devices for chronic wound care are developed.
|
|
| Locked | Locked | Locked |
Solutions for treating severe acute and chronic wounds are developed.
|
|
| Locked | Locked | Locked |
Chronic wound solutions are developed via portable oxygen-enrichment devices.
|
|
| Locked | Locked | Locked |
Topical hyperbaric oxygen therapy for wound healing is developed.
|
Detailed competitors of Vaporox
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vaporox
Complete news archive for Vaporox
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vaporox
Vaporox was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Vaporox is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
Alan Sage is the current CEO of Vaporox.
Vaporox is a funded company, having raised a total of $2.25M across 5 funding rounds to date.
Provider of clinical-stage veterinary medicine for treating dogs. The company is using patented Vaporous Hyperoxia Therapy (VHT) acts as a delivery system for oxygen, ultrasound waves, and drugs at the site of the wound. The flagship product, VHT-100 is FDA 510(k) cleared device.
Vaporox's top competitors include Natrox, Advanced Oxygen Therapy and EO2Concepts.
Vaporox has 3 investors. Key investors include Bioventus, Rockies Venture Club, and Innosphere.